Literature DB >> 23070603

Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.

Waseem Kaialy1, Ali Nokhodchi.   

Abstract

PURPOSE: To show for the first time the superior dry powder inhaler (DPI) performance of freeze dried mannitol in comparison to spray dried mannitol and commercial mannitol.
METHODS: Different mannitol powders were sieved to collect 63-90 μm particles and then analyzed in terms of size, shape, surface morphology, solid state, density, flowability. Salbutamol sulphate-mannitol aerosol formulations were evaluated in terms of homogeneity, SS-mannitol adhesion, and in vitro aerosolization performance.
RESULTS: Freeze dried mannitol demonstrated superior DPI performance with a fine particle fraction believed to be highest so far reported in literature for salbutamol sulphate under similar protocols (FPF = 46.9%). To lesser extent, spray dried mannitol produced better aerosolization performance than commercial mannitol. Freeze dried mannitol demonstrated elongated morphology, α-+β-+δ- polymorphic forms, and poor flowability whereas spray dried mannitol demonstrated spherical morphology, α-+β- polymorphic forms, and excellent flowability. Commercial mannitol demonstrated angular morphology, β- polymorphic form, and good flowability. Freeze dried mannitol demonstrated smoother surface than spray dried mannitol which in turn demonstrated smoother surface than commercial mannitol. FPF of SS increased as mannitol powder porosity increase.
CONCLUSIONS: Freeze drying under controlled conditions can be used as a potential technique to generate aerodynamically light mannitol particles for superior DPI performance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23070603     DOI: 10.1007/s11095-012-0892-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time.

Authors:  B H J Dickhoff; A H de Boer; D Lambregts; H W Frijlink
Journal:  Eur J Pharm Biopharm       Date:  2003-09       Impact factor: 5.571

2.  Three polymorphs (alpha, beta, and delta) of D-mannitol at 100 K.

Authors:  Frank R Fronczek; Haidy Nasr Kamel; Marc Slattery
Journal:  Acta Crystallogr C       Date:  2003-09-23       Impact factor: 1.172

3.  Dry powder inhaler device influence on carrier particle performance.

Authors:  Martin J Donovan; Sin Hyen Kim; Venkatramanan Raman; Hugh D Smyth
Journal:  J Pharm Sci       Date:  2011-11-17       Impact factor: 3.534

4.  Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.

Authors:  Martin J Donovan; Hugh D C Smyth
Journal:  Int J Pharm       Date:  2010-09-15       Impact factor: 5.875

5.  Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.

Authors:  R P Aquino; L Prota; G Auriemma; A Santoro; T Mencherini; G Colombo; P Russo
Journal:  Int J Pharm       Date:  2012-01-23       Impact factor: 5.875

6.  Effect of milling and sieving on functionality of dry powder inhalation products.

Authors:  H Steckel; P Markefka; H teWierik; R Kammelar
Journal:  Int J Pharm       Date:  2005-12-27       Impact factor: 5.875

Review 7.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

8.  The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.

Authors:  Waseem Kaialy; Hassan Larhrib; Gary P Martin; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

9.  Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.

Authors:  Waseem Kaialy; Gary P Martin; Martyn D Ticehurst; Paul Royall; Mohammad A Mohammad; John Murphy; Ali Nokhodchi
Journal:  AAPS J       Date:  2010-11-06       Impact factor: 4.009

10.  Interparticle forces in binary and ternary ordered powder mixes.

Authors:  J N Staniforth; J E Rees; F K Lai; J A Hersey
Journal:  J Pharm Pharmacol       Date:  1982-03       Impact factor: 3.765

View more
  4 in total

1.  Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.

Authors:  Waseem Kaialy; Tariq Hussain; Amjad Alhalaweh; Ali Nokhodchi
Journal:  Pharm Res       Date:  2013-08-06       Impact factor: 4.200

Review 2.  Influence of physical properties of carrier on the performance of dry powder inhalers.

Authors:  Tingting Peng; Shiqi Lin; Boyi Niu; Xinyi Wang; Ying Huang; Xuejuan Zhang; Ge Li; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2016-05-04       Impact factor: 11.413

Review 3.  Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2018-01-14

4.  Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.

Authors:  Carlos Molina; Waseem Kaialy; Qiao Chen; Daniel Commandeur; Ali Nokhodchi
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.